Article Details

How Analysts Rated Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Last Week?

Retrieved on: 2018-04-30 18:41:15

Tags for this article:

Click the tags to see associated articles and topics

How Analysts Rated Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Last Week?. View article details on hiswai:

Excerpt

<div><b>Benchmark Capital</b> Advsrs has 0.92% invested in Sarepta Therapeutics, Inc. (NASDAQ:SRPT). Hall Laurie J Trustee invested in 0.13% or 3,290 shares. Neuberger Berman Grp Limited Liability Corporation owns 17,775 shares or 0% of their US portfolio. Pnc Svcs Gru Inc holds 0.01% of its portfolio in ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo